Quick answer: GERD affects 20% of Western populations, yet proton pump inhibitors — prescribed to over 15 million Americans — suppress symptoms while accelerating the nutritional deficiencies, gut dysbiosis, and motility dysfunction that drive the disease. Functional medicine identifies the actual root causes of reflux: insufficient lower esophageal sphincter tone, delayed gastric emptying, small intestinal bacterial overgrowth, low stomach acid (hypochlorhydria), dietary triggers, and hiatal hernia — and provides evidence-based solutions that address the mechanism rather than masking acid production.
The GERD Paradox: When Acid Suppression Makes Things Worse
The pharmaceutical model of GERD assumes excess stomach acid is the problem. Yet the stomach is designed to be highly acidic (pH 1-3) — this acidity is essential for protein digestion, mineral absorption (iron, calcium, magnesium, zinc, B12), and killing ingested pathogens. Hydrochloric acid triggers the pyloric sphincter to open, propelling food into the small intestine. When stomach acid is suppressed pharmacologically, gastric emptying slows, bacterial overgrowth risk increases, and pressure in the distal esophagus rises — potentially worsening reflux events while eliminating the acid that previously burned the esophageal mucosa.
The emerging paradox: studies by Pimentel et al. and others suggest that in a significant subset of GERD patients — particularly those with bloating, belching, and postprandial symptoms — the underlying driver is insufficient stomach acid (hypochlorhydria) causing delayed gastric emptying and increased intraabdominal pressure. The low-acid stomach also predisposes to SIBO (Pimentel 2000 demonstrated 78% of IBS patients have SIBO, and hypochlorhydria is a primary predisposing factor). This creates a population of patients who are put on progressively higher doses of PPIs while the root cause worsens.
Root Cause Assessment: The Functional Medicine Reflux Workup
Proper functional medicine evaluation of GERD and reflux symptoms extends far beyond endoscopy and pH monitoring to identify the specific mechanism driving each patient’s presentation. A comprehensive workup includes:
Stomach acid testing: The Heidelberg pH capsule test (swallowed radio-transmitting capsule measuring gastric pH in response to bicarbonate challenge) is the gold standard for identifying hypochlorhydria, hyperchlorhydria, and acid secretion patterns. The more accessible Betaine HCl challenge (empirical titration with increasing HCl doses until warmth sensation indicates adequate acid) identifies hypochlorhydric patients who paradoxically improve on HCl supplementation rather than acid suppression.
Motility assessment: Gastric emptying scintigraphy quantifies gastroparesis — delayed emptying causes fundal distension that increases LES pressure and promotes regurgitation. Esophageal manometry identifies LES tone deficiency, ineffective esophageal motility, and achalasia. High-resolution esophageal impedance-pH monitoring distinguishes acid reflux, non-acid reflux, and gas reflux — critical for patients with persistent symptoms on PPI therapy who may not have acid reflux as the primary mechanism.
SIBO testing: Lactulose or glucose hydrogen/methane breath testing identifies SIBO, which produces intraluminal gas increasing intraabdominal pressure and promoting reflux. Pimentel 2002 demonstrated that SIBO treatment with rifaximin improved GERD symptoms in patients with concurrent SIBO, establishing the gut-esophagus connection.
H. pylori testing: H. pylori colonizes the gastric antrum and affects acid secretion in complex ways — initially increasing acid secretion (promoting ulcer formation) and with chronic infection potentially reducing acid as mucosal damage progresses. Urea breath test or stool antigen test are preferred over serology (which doesn’t distinguish active from past infection). H. pylori eradication is essential when present; Leontiadis 2004 Cochrane review confirmed that eradication heals peptic ulcers more effectively than acid suppression alone.
LES Dysfunction: The Central Mechanical Problem
The lower esophageal sphincter (LES) — a 3-4cm segment of tonically contracted smooth muscle at the esophagogastric junction — normally maintains pressure of 15-35 mmHg, preventing retrograde gastric content flow. Transient LES relaxations (TLESRs), distinct from swallowing-induced relaxations, are the primary mechanism of reflux episodes in both normal individuals and GERD patients. The frequency and duration of TLESRs are increased by: gastric distension (large meals, air swallowing, SIBO-related gas), lying down within 3 hours of eating, obesity (increased intraabdominal pressure), pregnancy, certain medications (anticholinergics, calcium channel blockers, theophylline), smoking (nicotine), alcohol, and chocolate (methylxanthines).
Hiatal hernia — herniation of the gastric fundus through the diaphragmatic hiatus — disrupts the crural diaphragm’s contribution to LES pressure and creates an acid pocket above the diaphragm that promotes reflux during TLESRs. Sliding hiatal hernias (Type I, 95% of cases) correlate with GERD severity; Type II-IV (paraesophageal) hernias require surgical evaluation given incarceration risk. Diaphragmatic breathing and core strengthening exercises improve the crural diaphragm’s contribution to LES pressure in mild hiatal hernia.
Diet and GERD: Beyond the Standard “Avoid List”
Standard dietary advice for GERD (avoid caffeine, alcohol, chocolate, citrus, tomatoes, spicy foods, fatty foods) is based largely on expert consensus and patient-reported triggers rather than high-quality RCT evidence. The functional medicine approach uses systematic food sensitivity testing and an elimination-reintroduction protocol to identify individual triggers, rather than universally restricting foods that may not be problematic for a given patient.
The Mediterranean dietary pattern shows consistent protective associations with GERD in observational data. Ness-Jensen et al. 2016 (Gut) found that each 10% increase in Mediterranean diet score reduced GERD prevalence 11%. Zalvan et al. 2017 (JAMA Otolaryngology) compared Mediterranean diet + alkaline water versus PPI therapy in laryngopharyngeal reflux (LPR) and found equivalent symptom reduction (63% vs 54% response) — with the dietary intervention achieving similar efficacy to PPI without acid suppression side effects.
Meal timing, portion size, and eating behavior are as clinically important as food composition. Large meal volumes distend the gastric fundus, triggering TLESRs and increasing LES pressure differential. Eating slowly, thorough mastication (reducing swallowed air), and stopping at 70% satiety reduce gastric distension. Avoiding supine position within 3 hours of eating is among the most evidence-supported GERD behavioral interventions — Kaltenbach et al. 2006 systematic review found consistent benefit across multiple studies. Elevating the head of the bed 6-8 inches (via bed wedge) reduces nocturnal acid exposure by 40% in patients with nighttime reflux symptoms.
PPI Side Effects: The Long-Term Cost of Acid Suppression
Proton pump inhibitors (omeprazole, pantoprazole, esomeprazole, lansoprazole) are among the most prescribed medications globally yet carry a substantial long-term side effect burden that is underappreciated in clinical practice. A 2019 systematic review in BMJ Open catalogued PPI-associated risks with varying evidence quality:
Nutrient malabsorption: Gastric acid is essential for ionizing calcium carbonate to calcium chloride for absorption; PPI use for more than 1 year increases hip fracture risk 44% (Yang 2006 JAMA). Vitamin B12 absorption requires acid-pepsin cleaving B12 from food proteins — Lam 2013 (JAMA, n=26,000) found PPIs associated with 65% increased B12 deficiency. Iron, zinc, and magnesium absorption are all pH-dependent; chronic PPI use produces clinically significant hypomagnesemia in 1-2% of users (Hess 2012). These deficiencies accumulate silently over years of use.
Infection risk: Gastric acid is a primary defense against enteric pathogens. Janarthanan 2012 (American Journal of Gastroenterology) found PPI use increased Clostridioides difficile infection risk 1.74-fold. Pneumonia risk increases 1.34-fold with PPI use (Sarkar 2008 Annals of Internal Medicine). Spontaneous bacterial peritonitis in cirrhotic patients increases dramatically.
Microbiome disruption: Acid-dependent sterilization of the stomach and proximal small intestine is fundamental to preventing intestinal bacterial overgrowth. Multiple studies confirm that PPI use is the strongest non-surgical predictor of SIBO development — Lo 2013 meta-analysis found OR 2.27 for SIBO in PPI users. This creates a vicious cycle: SIBO worsens reflux symptoms, driving higher PPI doses that worsen SIBO.
Rebound hypersecretion: Discontinuing PPIs after even 8 weeks of use produces rebound acid hypersecretion (Reimer 2009 Gastroenterology RCT) — acid production exceeding pre-treatment levels for weeks, causing symptomatic reflux that patients and physicians misinterpret as disease recurrence, perpetuating long-term unnecessary PPI dependence.
Natural Interventions with Evidence for GERD
Multiple natural interventions have randomized controlled trial evidence for GERD and reflux symptoms:
Melatonin: Pawlak 2013 and Pereira 2006 RCTs demonstrated that melatonin (6mg nightly) significantly reduced GERD symptoms. The mechanism involves melatonin receptors in the esophageal mucosa promoting LES tone and mucosal repair. De Conno 2007 compared melatonin to omeprazole and found superior symptom reduction with melatonin — a striking finding given the pharmacological potency of PPIs.
Aloe vera: Panahi et al. 2015 RCT (n=79) found that aloe vera syrup (10mL twice daily for 4 weeks) reduced GERD symptom scores by 50-75% for heartburn, belching, vomiting, acid regurgitation, food odynophagia, flatulence, and nausea — comparable to omeprazole 20mg. The mechanism involves mucosal soothing, anti-inflammatory effects, and possible motility improvement.
DGL (deglycyrrhizinated licorice): DGL promotes mucosal healing by stimulating mucus production and improving mucosal cell regeneration. Morgan 1985 double-blind trial demonstrated DGL equivalent to cimetidine for duodenal ulcer healing. Typical dosing: 760mg chewable tablets 20 minutes before meals — the chewing and salivary activation appears important for efficacy.
Slippery elm and marshmallow root: Mucilaginous herbs forming a protective coating on esophageal and gastric mucosa. Used empirically for centuries; mechanistic support from in vitro demulcent studies. Appropriate for symptomatic relief during the root cause correction period.
Betaine HCl: For confirmed hypochlorhydric patients, betaine HCl supplementation (500-750mg with protein-containing meals, titrated upward) normalizes gastric pH, improves protein digestion, and in many patients paradoxically resolves reflux symptoms. This counter-intuitive approach reflects the reality that many functional GERD patients have impaired acid secretion rather than excess acid production.
H. pylori Eradication: Natural and Pharmaceutical Approaches
H. pylori infects approximately 50% of the global population, though Western prevalence has fallen to 30-35%. Standard triple therapy (PPI + clarithromycin + amoxicillin for 14 days) achieves 70-85% eradication rates, with resistance to clarithromycin rising globally. Quadruple therapy (bismuth + PPI + metronidazole + tetracycline) achieves higher eradication rates in clarithromycin-resistant populations.
Natural adjuncts with evidence: mastic gum (Pistacia lentiscus resin) achieved 38.5% H. pylori eradication in Huwez 1998 pilot study — modest as monotherapy but potentially meaningful as adjunct. Broccoli sprouts (sulforaphane) reduced H. pylori colonization in gastric mucosa in Yanaka 2009 RCT. Cranberry juice (proanthocyanidins inhibiting H. pylori adhesion) showed 14% reduction in H. pylori-positive rates in Zhang 2005 RCT. Probiotic adjunctive therapy — Lactobacillus reuteri, L. acidophilus — reduces H. pylori load and improves eradication therapy side effect tolerance (Zheng 2013 meta-analysis).
Frequently Asked Questions
Can GERD be cured without medication?
Many cases of functional GERD — particularly those driven by dietary triggers, SIBO, hypochlorhydria, obesity, or hiatal hernia — can be resolved or dramatically improved without long-term medication. The key is identifying the root cause mechanism for each patient. Patients with severe esophagitis (Los Angeles grade C/D), Barrett’s esophagus, or large hiatal hernias typically require medical or surgical management, but even in these cases, functional interventions reduce medication burden and symptom frequency.
Why does my GERD seem worse after stopping my PPI?
This is rebound acid hypersecretion — a well-documented pharmacological phenomenon where stopping PPIs after even 8 weeks of use causes acid production to overshoot baseline for several weeks. This makes the GERD feel “worse” than before treatment began, creating the misimpression that the PPI is necessary. A supervised taper (gradual dose reduction over 4-8 weeks) while implementing lifestyle and dietary changes minimizes rebound hypersecretion and prevents relapse.
Is low stomach acid really a cause of GERD?
Yes — in a meaningful subset of GERD patients, particularly those with bloating, belching, early satiety, and postprandial heaviness. Hypochlorhydria causes delayed gastric emptying, bacterial overgrowth in the stomach and proximal small intestine, and increased intraabdominal gas pressure — all of which promote reflux events. The Betaine HCl challenge test and Heidelberg capsule test identify these patients, who paradoxically improve on HCl supplementation. Age-related hypochlorhydria (affecting up to 30% of those over 65) explains the high GERD burden in older populations despite decreasing acid secretion.
What is the connection between GERD and SIBO?
SIBO and GERD are bidirectionally related. SIBO produces hydrogen, methane, and hydrogen sulfide gas, increasing intragastric and intraabdominal pressure that promotes TLESRs and reflux events. PPI therapy — prescribed for GERD — suppresses gastric acid that normally sterilizes the proximal GI tract, predisposing to SIBO development. Multiple studies confirm PPI users have 2-3× higher SIBO rates. Treating SIBO with rifaximin, elemental diet, or targeted antimicrobial herbal protocols frequently improves GERD symptoms in patients with concurrent SIBO.
Reflux and GERD don’t have to be a lifelong medication sentence. At The Private Practice, we systematically identify the root causes — whether SIBO, hypochlorhydria, motility dysfunction, dietary triggers, or structural factors — and create personalized treatment plans that address the mechanism, not just the symptom. Call (810) 206-1402 to schedule your functional GI evaluation.